Banning nursing home visitors during coronavirus raises ethical questions with no simple answers
Physically, older people are among those most vulnerable to the coronavirus.
Apr 15, 2020
0
2
Physically, older people are among those most vulnerable to the coronavirus.
Apr 15, 2020
0
2
British drugmaker GlaxoSmithKline on Wednesday said its second quarter net profit rose 13.3 percent from a year earlier to £1.25 billion ($1.94 billion, 1.59 billion euros).
Jul 25, 2012
0
0
Private equity investment in hospitals has grown substantially in the 21st century, and it accelerated in the years leading up the COVID-19 pandemic. Now a new study of short-term acute care hospitals acquired by private ...
May 5, 2021
0
2
(HealthDay)—Physician business models are transforming, with a sustained shift away from independent practice, according to report released by the consulting firm Accenture.
Dec 11, 2012
0
0
(AP)—Danish pharmaceutical company Novo Nordisk A/S says first-quarter net profit rose 28 percent on strong sales of its diabetic drugs.
May 1, 2013
0
0
Addressing the obesity epidemic by preventing excess calorie consumption with government regulation of portion sizes is justifiable and could be an effective measure to help prevent obesity-related health problems and deaths, ...
Sep 18, 2012
0
0
(HealthDay)—Alternative payment models (APMs) have been and are being developed that can allow physicians to offer new and improved services to their patients, according to a report published by the American Medical Association ...
Jan 28, 2016
0
1
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in full-year net profit on Thursday.
Jan 31, 2013
0
0
Pharmaceutical company GlaxoSmithKline says its net profit rose 50 percent in the third quarter to 808 million pounds ($986 million) thanks in part to strong sales of its vaccine products.
Oct 26, 2016
0
0
(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Nov 1, 2012
0
0